MCD
52
2
TGT
22
2
FSLR
54
7
NAVI
52
5
FITB
63
3
ES
34
3
ADBE
49
3
GT
62
6
BAC
53
3
LEG
36
4
PGR
65
2
PLD
56
8
NKE
36
6
WBA
48
4
RSG
71
3
CCI
31
3
FLR
58
3
MET
72
5
ORCL
65
-2
BBY
46
10
MCD
52
2
TGT
22
2
FSLR
54
7
NAVI
52
5
FITB
63
3
ES
34
3
ADBE
49
3
GT
62
6
BAC
53
3
LEG
36
4
PGR
65
2
PLD
56
8
NKE
36
6
WBA
48
4
RSG
71
3
CCI
31
3
FLR
58
3
MET
72
5
ORCL
65
-2
BBY
46
10
Financhill
Back

Centessa Pharmaceuticals PLC 10K Form

Buy
77

CNTA
Centessa Pharmaceuticals PLC

Last Price:
17.01
Seasonality Move:
7.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CNTA News And Ratings

See the #1 stock for the next 7 days that we like better than CNTA

CNTA Financial Statistics

Sales & Book Value

Annual Sales: $6.85M
Cash Flow: $-21.42M
Price / Cash Flow: 0
Annual Sales: $3.79
Price / Book: 4.5

Profitability

EPS (TTM): -1.52000
Net Income (TTM): $-161.27M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Centessa Pharmaceuticals PLC Earnings Forecast

Key Centessa Pharmaceuticals PLC Financial Ratios

  • The Research & Development expenses have been 1,815.34% of Revenue.
  • The Interest Expense is -6.56% of Operating Income.
  • The Net Earning history of CNTA is -2,204.65% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 1 years.

Centessa Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CNTA
Website: centessa.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CNTA Technical Analysis vs Fundamental Analysis

Buy
77
Centessa Pharmaceuticals PLC (CNTA) is a Buy

Is Centessa Pharmaceuticals PLC a Buy or a Sell?